Your browser doesn't support javascript.
loading
CD28 homodimer interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial sepsis and gram-negative bacterial peritonitis.
Ramachandran, Girish; Kaempfer, Raymond; Chung, Chun-Shiang; Shirvan, Anat; Chahin, Abdullah B; Palardy, John E; Parejo, Nicolas A; Chen, Yaping; Whitford, Melissa; Arad, Gila; Hillman, Dalia; Shemesh, Ronen; Blackwelder, William; Ayala, Alfred; Cross, Alan S; Opal, Steven M.
Afiliação
  • Ramachandran G; Center for Vaccine Development, University of Maryland Medical School, Baltimore.
  • Kaempfer R; Institute of Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University, Jerusalem.
  • Chung CS; Faculty of Medicine, The Alpert Medical School at Brown University and Rhode Island Hospital, Providence.
  • Shirvan A; Atox Bio, Rehovot, Israel.
  • Chahin AB; Faculty of Medicine, The Alpert Medical School at Brown University and Rhode Island Hospital, Providence.
  • Palardy JE; Faculty of Medicine, The Alpert Medical School at Brown University and Rhode Island Hospital, Providence.
  • Parejo NA; Faculty of Medicine, The Alpert Medical School at Brown University and Rhode Island Hospital, Providence.
  • Chen Y; Faculty of Medicine, The Alpert Medical School at Brown University and Rhode Island Hospital, Providence.
  • Whitford M; Center for Vaccine Development, University of Maryland Medical School, Baltimore.
  • Arad G; Institute of Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University, Jerusalem.
  • Hillman D; Institute of Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University, Jerusalem.
  • Shemesh R; Atox Bio, Rehovot, Israel.
  • Blackwelder W; Center for Vaccine Development, University of Maryland Medical School, Baltimore.
  • Ayala A; Faculty of Medicine, The Alpert Medical School at Brown University and Rhode Island Hospital, Providence.
  • Cross AS; Center for Vaccine Development, University of Maryland Medical School, Baltimore.
  • Opal SM; Faculty of Medicine, The Alpert Medical School at Brown University and Rhode Island Hospital, Providence.
J Infect Dis ; 211(6): 995-1003, 2015 Mar 15.
Article em En | MEDLINE | ID: mdl-25305323
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peritonite / Antígenos CD28 / Sepse / Infecções por Escherichia coli / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2015 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peritonite / Antígenos CD28 / Sepse / Infecções por Escherichia coli / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2015 Tipo de documento: Article País de publicação: Estados Unidos